newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients Trial expanded to South America, with regulatory approvals for Argentina and Brazil Target trial enrollment increased to 160 patients Topline trial data anticip